From trauma to tau: Researchers tie brain injury to toxic form of protein

University of Texas Medical Branch at Galveston researchers have uncovered what may be a key molecular mechanism behind the lasting damage done by traumatic brain injury.

The discovery centers on a particular form of a protein that neuroscientists call tau, which has also been associated with Alzheimer's disease and other . Under ordinary conditions, tau is essential to neuron health, but in Alzheimer's the into two abnormal forms: so-called "," and collections of two, three, or four or more tau units known as "oligomers."

Neurofibrillary tangles are not believed to be harmful, but tau oligomers are toxic to . They also are thought to have an additional damaging property—when they come into contact with healthy , they cause them to also clump together into oligomers, and so spread toxic tau oligomers to other parts of the brain.

Now, in experiments with , using novel antibodies developed at UTMB, scientists have found that traumatic brain injuries also generate tau oligomers. The destructive protein assemblages formed within four hours after injury and persisted for at least two weeks—long enough to suggest that they might contribute to lasting brain damage.

Significantly, the rats used in the experiments were normal, unlike the genetically modified animals used in most tau research. The findings are thus likely to be more relevant to human traumatic brain injuries.

"Although people have given some attention to the formation of neurofibrillary tangles after , we were the first to look at tau oligomers, because we have an antibody that allows us to separate them out and see how much of the total tau is the toxic species," said Bridget Hawkins, lead author of a paper on the research now online in the Journal of Biological Chemistry. "We saw that it's a substantial amount—enough to play an important role in the effects of traumatic brain injury."

Those effects can include memory deficits, which have been recently shown by UTMB researchers to be induced by tau oligomers. Other long-term ramifications of TBI include seizures, and disruptions in the sleep-wake cycle. The UTMB scientists hypothesize that these problems could be avoided if physicians had a way to stop the process of tau oligomerization.

One possibility is a treatment based on the antibodies used to label tau oligomers in this project, which were developed as part of an effort to develop a vaccine against different neurodegenerative disorders.

"We have antibodies that can specifically target these tau oligomers without interfering with the function of healthy tau," said UTMB associate professor Rakez Kayed, the senior author on the paper. "This is a new approach—we're starting by targeting them in animals—but we hope to eventually humanize these antibodies for clinical trials."

Related Stories

Untangling the mysteries of Alzheimer's

Feb 02, 2012

One of the most distinctive signs of the development of Alzheimer's disease is a change in the behavior of a protein that neuroscientists call tau. In normal brains, tau is present in individual units essential to neuron ...

Neuronal activity induces tau release from healthy neurons

Feb 15, 2013

Researchers from King's College London have discovered that neuronal activity can stimulate tau release from healthy neurons in the absence of cell death. The results published by Diane Hanger and her colleagues in EMBO re ...

Recommended for you

Emotional adjustment following traumatic brain injury

Oct 24, 2014

Life after a traumatic brain injury resulting from a car accident, a bad fall or a neurodegenerative disease changes a person forever. But the injury doesn't solely affect the survivor – the lives of their spouse or partner ...

New ALS associated gene identified using innovative strategy

Oct 22, 2014

Using an innovative exome sequencing strategy, a team of international scientists led by John Landers, PhD, at the University of Massachusetts Medical School has shown that TUBA4A, the gene encoding the Tubulin Alpha 4A protein, ...

User comments